BLUE - bluebird bio, Inc.
IEX Last Trade
8.71
-0.040 -0.459%
Share volume: 0
Last Updated: Fri 27 Dec 2024 03:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-1.15%
PREVIOUS CLOSE
CHG
CHG%
$8.75
-0.04
-0.46%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-09 | 2022-08-04 | 2022-11-07 | 2023-03-29 | 2023-05-09 | 2023-08-08 | 2023-11-07 | |
| Total revenue | 1.945 M | 1.519 M | 71.000 K | 62.000 K | 2.381 M | 6.890 M | 12.392 M | |
| Cost of revenue | 8.310 M | 1.745 M | 0.000 | 22.000 K | 3.376 M | 9.564 M | 10.955 M | |
| Gross profit | -6.365 M | -226.000 K | 71.000 K | 40.000 K | -995.000 K | -2.674 M | 1.437 M | |
| 96.45% | 131.42% | -43.66% | -2,587.50% | -168.74% | 153.74% | |||
| Operating expenses | 113.981 M | 100.535 M | 86.551 M | 76.605 M | 83.498 M | 82.623 M | 86.166 M | |
| Selling general and admin | 36.106 M | 36.694 M | 33.402 M | 30.706 M | 37.354 M | 40.349 M | 40.703 M | |
| Research and development | 77.875 M | 63.841 M | 53.149 M | 45.899 M | 46.144 M | 42.274 M | 45.463 M | |
| Total expenses | 122.291 M | 102.280 M | 86.551 M | 76.627 M | 86.874 M | 92.187 M | 97.121 M | |
| -16.36% | -15.38% | -11.47% | 13.37% | 6.12% | 5.35% | |||
| Operating income | -120.346 M | -100.761 M | -86.480 M | -76.565 M | -84.493 M | -85.297 M | -84.729 M | |
| Ebit | -120.346 M | -100.761 M | -86.480 M | -76.565 M | -84.493 M | -85.297 M | -84.729 M | |
| Pretax income | -122.152 M | -100.138 M | -76.513 M | 32.342 M | 21.240 M | -72.988 M | -71.731 M | |
| -18.02% | -23.59% | -142.27% | -34.33% | -443.63% | -1.72% | |||
| Income tax | 0.000 | 0.000 | 7.000 K | 110.000 K | 0.000 | -80.000 K | 0.000 | |
| Net income basic | -122.152 M | -100.138 M | -76.520 M | 32.232 M | 21.240 M | -72.908 M | -71.731 M | |
| 18.02% | 23.59% | 142.12% | -34.10% | -443.26% | 1.61% | |||
| Net income | -122.152 M | -100.138 M | -76.520 M | 32.232 M | 21.240 M | -72.908 M | -71.731 M | |
| 18.02% | 23.59% | 142.12% | -34.10% | -443.26% | 1.61% |